|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1956)) |
IUPAC Name ![]() |
| 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)ethan-1-ol |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 599 | hydroxyzine |
Synonyms ![]() |
| Atarax® |
| hydroxyzine hydrochloride |
| hydroxyzine pamoate |
| Vistaril® |
Database Links ![]() |
|
| CAS Registry No. | 68-88-2 |
| ChEMBL Ligand | CHEMBL896 |
| DrugBank Ligand | DB00557 |
| PubChem CID | 3658 |
| Search Google for chemical match using the InChIKey | ZQDWXGKKHFNSQK-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | ZQDWXGKKHFNSQK |
| Search PubMed clinical trials | hydroxyzine |
| Search PubMed titles | hydroxyzine |
| Search PubMed titles/abstracts | hydroxyzine |
| Wikipedia | Hydroxyzine |
| Comments |
| Hydroxyzine is a first-generation diphenylmethane and piperazine class antihistamine. Second-generation antihistamine cetirizine is one of the metabolites of hydroxyzine, but cetirizine differs in that it appears not to cross the blood-brain barrier to any significant level. |